MediWound (NASDAQ: MDWD) Shares New EscharEx® Data at Leading Conferences

April 7, 2026

Key Developments MediWound (NASDAQ: MDWD) announced it will present new clinical data related to its EscharEx® technology at prominent wound care conferences. The fresh findings highlight the efficacy and safety profile of EscharEx®, a proprietary treatment targeting chronic and hard-to-heal wounds. This initiative underscores MediWound’s commitment to advancing wound healing solutions and engaging with the medical community through dissemination of new evidence. The company aims to increase awareness and adoption…

Read More >>